On January 26, 2023, Principal Deputy Commissioner Janet Woodcock released a statement regarding the current state of cannabidiol (CBD) regulation by the FDA and a growing need for a “new […] Read More >>
As the regulatory landscape continues to evolve for the nascent CBD-hemp industry in the USA, many have questioned whether cannabidiol (CBD) the non-psychoactive component naturally occurring in hemp is generally […] Read More >>